General Information of the Compound
Compound ID
CP0519183
Compound Name
(1H-Benzoimidazol-2-yl)-(1,2,3,4-tetrahydrophenanthren-4-yl)amine
    Show/Hide
Structure
Formula
C21H19N3
Molecular Weight
313.404
Canonical SMILES
C1CC(Nc2nc3ccccc3[nH]2)c2c(C1)ccc1ccccc21
    Show/Hide
InChI
InChI=1S/C21H19N3/c1-2-8-16-14(6-1)12-13-15-7-5-11-19(20(15)16)24-21-22-17-9-3-4-10-18(17)23-21/h1-4,6,8-10,12-13,19H,5,7,11H2,(H2,22,23,24)
    Show/Hide
InChIKey
ZBIBQVJNOROCLB-UHFFFAOYSA-N
Physicochemical Property
logP
5.2056
Rotatable Bonds
2
Heavy Atom Count
24
Polar Areas
40.71
Hydrogen Bond Donor Count
2
Hydrogen Bond Acceptor Count
2
Complexity
24

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 25157550
SID: 57251637
ChEMBL ID
CHEMBL453140
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT02468, Small conductance calcium-activated potassium channel protein 3
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000006 HEK293 Homo sapiens (Human)  1
1
Kd = 31 nM
   TI
   LI
   LO
   TS